Snowball logo
logo
X2S1

SINOPHARM GROUP 1/5/O.N.

€8.70€0.00  (0%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025
Revenue
Total revenue
521,051.2552,147.6596,569.6584,507.9575,167.9
COGS
477,000.6504,713.5548,057.9540,252.5533,495.9
Gross Profit
44,050.647,434.148,511.744,255.441,672
Operating Expenses & Income
Operating Income
21,013.122,540.622,27717,770.517,079.2
Total Operating Expenses
500,038.1529,606.9574,292.6566,737.4558,088.6
R&D Expenses
-----
Selling General & Admin Expenses
23,198.524,903.126,149.825,572.224,018.9
Earnings from Continuing Operations
Interest Expense
(3,756.8)(3,520.3)(2,956.6)(2,734)(2,300.1)
Interest Income
558.6542.8743.4617500.2
Income Tax Expense
-----
Net Income
Net Income
7,758.68,525.79,053.87,049.77,155.1
Supplemental
EBIT
-22,084.122,468.716,734.917,099.7
EBITDA
-26,249.226,89921,468.621,388.8
In millions of EUR, except % and values per 1 share